Copyright Acumen research and consulting. All rights reserved.

Computed Tomography (CT) Market (By Technology :Extreme Multidetector CT, Iterative Reconstruction Algorithms, Dual-Energy CT , Cone-Beam CT, Portable CT, and Phase-Contrast CT; By Application: Oncology, Neurology, Cardiology, Vascular, Musculoskeletal, and Others; By End-User: Hospitals, Diagnostic Imaging Center, and Ambulatory Imaging Center) - Global Industry Analysis, Market Size, Opportunities and Forecast 2021-2028

  • Category : Healthcare and Pharmaceuticals
  • Pages : 250 Pages
  • Format: PDF
  • Status : Published

Select Access Type

  • Single User License : USD 4500
  • Multi User License : USD 9000

The global computed tomography (CT) market accounted US$ 7,544.3 Mn in 2020 with a significant CAGR of 7.0% during the analysis period of 2021 to 2028.

Radiological Society of North America, Inc. (RSNA) defines computed tomography (CT) as a diagnostic imaging test that is intended to create detailed images of internal organs, bones, soft tissues, and blood vessels. The cross sectional images generated during a CT scan be reformatted in multiple planes, and can even generate 3D images that can be easily viewed on a computer monitor, printed on film or transferred to electronic media.

Report coverage

Market Computed Tomography (CT) Market
Analysis Period 2017 - 2028
Base Year 2020
Forecast Data 2021 - 2028
Segments Covered By Technology, By Application, By End-User, and By Geography
Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled CANON MEDICAL SYSTEMS CORPORATION, General Electric Company, Koninklijke Philips N.V., Siemens Healthcare GmbH, FUJIFILM Healthcare, Shenzhen Anke High-Tech Co., NeuroLogica Corp., and among others
Report Coverage
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
Customization Scope

10 hrs of free customization and expert consultation

 

Key takeaway:

Big calls for computed tomography amid COVID-19

The Radiological Society of North America report states that several chest CT findings have reported abnormalities in 70% of RT-PCR test proven COVID-19 cases. This is due to the incidence of normal chest CT findings in symptomatic patients suffering from COVID-19 estimated at about 10.6%. Additionally, normal chest CT findings are more frequently visualized at around 4-5 days after symptom onset, hence, a non-negligible number of symptomatic cases with normal chest CT findings was witnessed during the later stage of the infection. Furthermore, several CT classification schemes have been developed as a guide to assist radiologists to gain a better understanding of the spectrum of typical and atypical manifestations of COVID-19. These schemes serve as a useful tool for the research by offering a standardized way of reporting CT findings and their likelihood of presenting in times of COVID-19 infection.

CT for detection of illness and injury among children has gained significant importance in the global market

AS per the U.S. Department of Health and Human Services report, CT can prove to be a life saving tool for diagnosing illness and injuries among children. For instance, approx. 5 to 9 million CT examinations are performed annually on children in the US. Additionally, CT proves to be a largest contributor to medical radiation exposure among the US population. For records, about 12% of diagnostic radiological procedures in large US hospitals are estimated to account for approx. 49% of the US populations’ collective radiation dose from all medical X-ray examinations. Such factors propel the growth of global computed tomography market during the forecast period.

Technological advancement have gained significant attention in the worldwide market

As per the article released by Annualreviews.org, there has been several notable advancements in CT technology will have a significant clinical impact on the market, including extreme multidetector CT, iterative reconstruction algorithms, dual-energy CT, cone-beam CT, portable CT, and so on. Apart from that, the increased scope of clinical application made possible by fast multidetector helical CT scanners resulted in rising utilization. For example, multidetector CT imparts a higher dose profile as compared to single detector CT as much as 27% higher in the plane and 69% higher in the adjacent plane of the scanned areas. Such factors have positive influence for the growth of global CT market.

Market Segmentation

The global computed tomography (CT) market is segmented as technology, application, and end-user. Based on technology, the market is segmented as extreme multidetector CT, iterative reconstruction algorithms, dual-energy CT, cone-beam CT, portable CT, and phase-contrast CT. By application, the market is segmented as oncology, neurology, cardiology, vascular, musculoskeletal, and others. By end-user, the market is segmented as hospitals, diagnostic imaging center, and ambulatory imaging center.

In terms of technology, multidetector CT will record a notable share during the analysis period of 2021 to 2028. The high temporal solution and wide coverage offered by extreme multidetector CT represents a drastic shift and attention towards an imaging modality offering solely anatomical data. This technology is widely adopted for cardiac related disorders due to its high temporal resolution.

Based on application, oncology held a significant share and will continue to do so till the forecast period. The National Library of Medicine (NLM) report states that CT imaging has attracted significant attention in oncology segment due to its follow-up imaging to monitor accurate treatment response. Additionally, CT imaging has become ubiquitous in veterinary medicine because of increased availability of imaging modality. Such factors have impacted positively for the segmental growth ultimately resulting in the global CT market.

Regional Landscape

North America dominates the CT market

North America dominates the CT market and will continue similar trend of recording maximum share during the forecast period of 2021 to 2028. Widely adoption of CT for lung cancer detection has shown promising growth over the years. As per the American Cancer Society report, screening with low-dose spiral computed tomography (LDCT) has shown to reduce lung cancer mortality rate by about 20% as compared to standard X-ray procedures. Further, the American Cancer Society guidelines for the early detection of lung cancer have shown high volume, high quality lug cancer screening programs utilizing CT. Such factors have gained significant attention responsible for the regional growth ultimately contributing for the overall market growth.

Competitive Landscape

The key players profiled in the report of global computed tomography market have focused in growth strategies, involving new and innovative product launches, mergers & acquisitions, and partnerships. The prominent players of the global computed tomography market involve CANON MEDICAL SYSTEMS CORPORATION, General Electric Company, Koninklijke Philips N.V., Siemens Healthcare GmbH, FUJIFILM Healthcare, Shenzhen Anke High-Tech Co., NeuroLogica Corp., and among others

Market Segmentation

Market By Technology

  • Extreme Multidetector CT
  • Iterative Reconstruction Algorithms
  • Dual-Energy CT
  • Cone-Beam CT
  • Portable CT
  • Phase-Contrast CT

Market By Application

Market By End-User

  • Hospitals
  • Diagnostic Imaging Center
  • Ambulatory Imaging Center

Market By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil 
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa